Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126816111 | 12681611 | 1 | I | 201608 | 20160810 | 20160824 | 20160824 | EXP | FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-066798 | BRISTOL MYERS SQUIBB | 49.55 | YR | F | Y | 60.50000 | KG | 20160824 | CN | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126816111 | 12681611 | 1 | PS | NULOJIX | BELATACEPT | 1 | Intravenous (not otherwise specified) | 300 MG, QMO | Y | 125288 | 300 | MG | POWDER FOR SOLUTION FOR INFUSION | /month | |||||
| 126816111 | 12681611 | 2 | SS | CELLCEPT | MYCOPHENOLATE MOFETILMYCOPHENOLATE MOFETIL HYDROCHLORIDE | 1 | Oral | 750 UNK, UNK | Y | 0 | 750 | MG | TABLET | BID | |||||
| 126816111 | 12681611 | 3 | SS | CELLCEPT | MYCOPHENOLATE MOFETILMYCOPHENOLATE MOFETIL HYDROCHLORIDE | 1 | Oral | 250 MG, UNK | Y | 0 | 250 | MG | TABLET | BID | |||||
| 126816111 | 12681611 | 4 | SS | ROVALCYTE | VALGANCICLOVIR HYDROCHLORIDE | 1 | Unknown | 1 DF, UNK | Y | 0 | 1 | DF | FILM-COATED TABLET | ||||||
| 126816111 | 12681611 | 5 | SS | TRIFLUCAN | FLUCONAZOLE | 1 | Oral | 200 MG, QD | Y | 0 | 200 | MG | CAPSULE | QD | |||||
| 126816111 | 12681611 | 6 | SS | AMLOR | AMLODIPINE BESYLATE | 1 | Oral | 1 DF, QD | Y | 0 | 1 | DF | QD | ||||||
| 126816111 | 12681611 | 7 | SS | INEXIUM /01479302/ | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 1 DF, QHS | Y | 0 | 1 | DF | GASTRO-RESISTANT TABLET | QD | |||||
| 126816111 | 12681611 | 8 | SS | PRIMPERAN | METOCLOPRAMIDE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 10 MG, TID | Y | 0 | 10 | MG | TID | ||||||
| 126816111 | 12681611 | 9 | SS | DOLIPRANE | ACETAMINOPHEN | 1 | Oral | 1 G, TID | Y | 0 | 1 | G | TID | ||||||
| 126816111 | 12681611 | 10 | C | TENORMIN | ATENOLOL | 1 | Unknown | 50 MG, UNK | U | 0 | 50 | MG | |||||||
| 126816111 | 12681611 | 11 | C | ATENOLOL. | ATENOLOL | 1 | Oral | 1 DF, QD | U | 0 | 1 | DF | FILM-COATED TABLET | QD | |||||
| 126816111 | 12681611 | 12 | C | SOLUPRED /00016201/ | PREDNISOLONE | 1 | Oral | 17.5 MG, QD | U | 0 | 17.5 | MG | QD | ||||||
| 126816111 | 12681611 | 13 | C | ARANESP | DARBEPOETIN ALFA | 1 | Subcutaneous | 100 ?G, Q2WK | U | 0 | 100 | UG | QOW | ||||||
| 126816111 | 12681611 | 14 | C | SODIUM BICARBONATE ATLANTIC | 2 | Oral | 2 G, TID | U | 0 | 2 | G | TID | |||||||
| 126816111 | 12681611 | 15 | C | FORLAX | POLYETHYLENE GLYCOL 4000 | 1 | Oral | 10 G, QD | U | 0 | 10 | G | QD | ||||||
| 126816111 | 12681611 | 16 | C | ZOPHREN /00955301/ | ONDANSETRON | 1 | Oral | 4 MG, QD | U | 0 | 4 | MG | TABLET | QD | |||||
| 126816111 | 12681611 | 17 | C | MAGNE B6 /00869101/ | 2 | Oral | 1 DF, QD | U | 0 | 1 | DF | QD | |||||||
| 126816111 | 12681611 | 18 | C | ATENOLOL ARROW | 2 | Unknown | 1 TAB, QD | U | 0 | 1 | DF | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126816111 | 12681611 | 1 | Immunosuppression |
| 126816111 | 12681611 | 2 | Immunosuppression |
| 126816111 | 12681611 | 4 | Product used for unknown indication |
| 126816111 | 12681611 | 5 | Product used for unknown indication |
| 126816111 | 12681611 | 6 | Product used for unknown indication |
| 126816111 | 12681611 | 7 | Product used for unknown indication |
| 126816111 | 12681611 | 8 | Product used for unknown indication |
| 126816111 | 12681611 | 9 | Product used for unknown indication |
| 126816111 | 12681611 | 10 | Product used for unknown indication |
| 126816111 | 12681611 | 11 | Product used for unknown indication |
| 126816111 | 12681611 | 12 | Product used for unknown indication |
| 126816111 | 12681611 | 13 | Product used for unknown indication |
| 126816111 | 12681611 | 14 | Product used for unknown indication |
| 126816111 | 12681611 | 15 | Product used for unknown indication |
| 126816111 | 12681611 | 16 | Product used for unknown indication |
| 126816111 | 12681611 | 17 | Product used for unknown indication |
| 126816111 | 12681611 | 18 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126816111 | 12681611 | HO |
| 126816111 | 12681611 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126816111 | 12681611 | Agranulocytosis | |
| 126816111 | 12681611 | Neutropenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126816111 | 12681611 | 1 | 20160428 | 0 |